TrialClinical and translational science2024

Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu-like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll-like receptor 7 agonist ruzotolimod.

Qiudi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.